| |
| |
|
| Insider
Information: |
Mitchell Dean J |
| Relationship: |
Director |
| City: |
Plainsboro |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
716,524 |
|
|
Indirect Shares
|
750 |
|
|
| Direct
Value |
$4,039,052 |
|
|
|
Indirect Value
|
$25,430 |
|
|
| Total
Shares |
717,274 |
|
|
| Total
Value |
$4,064,482 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 33.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
President, U.S. Primar... |
2003-09-10 |
60,000 |
2003-09-10 |
567 |
Premium* |
|
|
MGI Pharma Inc |
MOGN |
President, MGI, GP, In... |
2005-10-05 |
3,391 |
2005-10-05 |
183 |
Premium* |
|
|
ISTA Pharmaceuticals Inc |
ISTA |
Director |
2008-12-10 |
4,932 |
2007-10-11 |
0 |
Premium* |
|
|
Talecris Biotherapeutics Holding... |
TLCR |
Director |
2011-06-01 |
0 |
2010-04-01 |
0 |
Premium* |
|
|
Precigen Inc |
PGEN |
Director |
2024-03-14 |
503,183 |
|
0 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
|
2023-05-02 |
70,018 |
2015-04-22 |
0 |
Premium* |
|
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2015-11-17 |
0 |
Premium* |
|
|
Praxis Precision Medicines, Inc. |
PRAX |
Director |
2023-03-24 |
75,000 |
2023-03-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGEN |
Precigen Inc |
Director |
– • – |
2024-03-14 |
4 |
A |
$1.43 |
$56,499 |
D/D |
39,510 |
503,183 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2024-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
106,837 |
463,673 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2024-02-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(103,000) |
0 |
0 |
- |
|
| IMGN |
Immunogen Inc |
|
– • – |
2023-09-22 |
4/A |
OE |
$14.70 |
$147,000 |
D/D |
10,000 |
103,000 |
0 |
- |
|
| IMGN |
Immunogen Inc |
|
– • – |
2023-09-22 |
4 |
OE |
$14.70 |
$147,000 |
D/D |
10,000 |
152,667 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2023-09-22 |
4 |
B |
$1.41 |
$35,250 |
D/D |
25,000 |
356,836 |
2.39 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
|
– • – |
2023-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
9,132 |
70,018 |
0 |
- |
|
| PRAX |
Praxis Precision Medicine... |
Director |
– • – |
2023-03-24 |
4 |
B |
$0.84 |
$41,815 |
D/D |
50,000 |
75,000 |
2.39 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2023-03-09 |
4 |
A |
$1.17 |
$56,499 |
D/D |
48,290 |
331,836 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2023-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
61,576 |
283,546 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
|
– • – |
2022-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
9,852 |
60,886 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2022-03-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,212 |
221,970 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2022-02-22 |
4 |
A |
$2.03 |
$56,499 |
D/D |
27,832 |
205,758 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2021-09-03 |
4 |
OE |
$1.84 |
$321,400 |
D/D |
83,000 |
93,000 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2021-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
9,828 |
51,034 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2021-03-25 |
4 |
A |
$7.71 |
$56,499 |
D/D |
7,328 |
177,926 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2021-03-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,189 |
170,598 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2021-03-03 |
4 |
OE |
$5.69 |
$16,888 |
D/D |
2,968 |
108,409 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2020-06-19 |
4 |
OE |
$3.17 |
$9,409 |
D/D |
2,968 |
105,441 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2020-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,635 |
41,206 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2020-03-13 |
4 |
A |
$2.01 |
$56,499 |
D/D |
28,109 |
102,473 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2020-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,703 |
74,364 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2019-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,385 |
34,571 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2019-03-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,911 |
49,661 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2019-03-12 |
4 |
OE |
$3.17 |
$28,232 |
D/D |
8,906 |
41,750 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
